Patent · US Active

Reagents, methods, and systems for detecting methicillin-resistant Staphylococcus

US8735554B2 · kind B2 · utility

2Cited by
0References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2009
Grant dateMay 27, 2014
Priority date
Expiry dateApr 10, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.